Biogen Inc (NASDAQ: BIIB)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 04/29/2022
Closing price: 207.44
Support price level: | $202.09 |
Resistance price level: | $219.92 |
Relative strength index (14-day RSI) | 43.5 |
Beta | 0.60 |
- Volatility is forecast to rise over the next month.
- BIIB is below its 200-day moving average - additional caution warranted in long positions.
Low | High | Price as % of Range |
$193.77 | $414.71 | 9.0% |
200 day | 50 day | 20 day | 10 day |
$258.25 | $209.13 | $212.10 | $213.07 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
44.2% | 40.3% | 40.7% | 46.5% |
- 11.1% in the next week.
- 26.3% in the next month.
- 105.3% in the next year.
Company news for Biogen Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks